Table 1.
Clinical and echocardiographic characteristics of patients included in this study.
| TAV | BAV | TAVdil | BAVdil | p-Value | |
|---|---|---|---|---|---|
| n | 33 | 62 | 35 | 82 | |
| Age (years) | 47 ± 2 | 41 ± 2 | 63 ± 2 | 52 ± 2 | 3.9 × 10−11 **, b,c,d |
| Sex (male/female) | (25/8) | (45/17) | (22/13) | (58/24) | 0.670 |
| Body weight (kg) | 71.32 ± 2.4 | 71.00 ± 2.0 | 80.50 ± 11.5 | 76.52 ± 1.8 | 0.183 |
| Severe aortic stenosis (mean gradient ≥ 40 mm Hg) | 0 (0%) | 3 (5%) | 0 (0%) | 19 (23%) | 2.1 × 10−5 ** |
| Aortic valve gradient (mean, mm Hg) | 3.57 ± 1.0 | 12.04 ± 1.8 | 2.85 ± 0.8 | 24.75 ± 2.6 | 5.5 × 10−12 **, b,d |
| Left ventricle diastolic diameter (mm) | 50.22 ± 0.9 | 52.20 ± 0.8 | 53.48 ± 1.0 | 53.79 ± 1.0 | 0.100 |
| Left ventricle systolic diameter (mm) | 30.35 ± 1.2 | 32.56 ± 0.8 | 30.01 ± 0.9 | 33.36 ± 0.9 | 0.175 |
| Left ventricular ejection fraction (%) | 71.92 ± 1.9 | 70.72 ± 1.2 | 70.86 ± 1.8 | 69.18 ± 1.1 | 0.568 |
| Aortic root diameter (mm) | 33.06 ± 0.8 | 33.93 ± 0.8 | 41.94 ± 1.2 | 39.32 ± 0.6 | 2.4 × 10−13 **, b,c |
| Ascending aorta diameter (mm) | 30.81 ± 0.6 | 32.56 ± 0.4 | 44.88 ± 0.7 | 44.36 ± 0.6 | 5.5 × 10−47 **, b,c |
TAV tricuspid aortic valve; BAV bicuspid aortic valve patients; BAVdil patients with bicuspid aortic valve and aortic dilation * Significant values (Overall p < 0.01); a, p < 0.05 TAV vs. BAV; b, p < 0.05 BAV vs. BAVdil; c, p < 0.05 TAV vs. TAVdil; d, p < 0.05 BAVdil vs. TAVdil. ** p-value < 0.01.